Spero Therapeutics, Inc. (SPRO)
2.27
-0.02
(-0.87%)
USD |
NASDAQ |
Dec 16, 16:00
2.285
+0.02
(+0.66%)
After-Hours: 20:00
Spero Therapeutics Gross Profit (Annual): 27.39M for Dec. 31, 2024
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Omeros Corp. | -0.95M |
| GeoVax Labs, Inc. | 3.859M |
| Vistagen Therapeutics, Inc. | -0.149M |
| Daré Bioscience, Inc. | -0.5035M |
| Hyperion DeFi, Inc. | -4.998M |